-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Decibel Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2020 to 2022.
- Decibel Therapeutics, Inc. Depreciation for the quarter ending March 31, 2023 was $340K, a 7.36% decline year-over-year.
- Decibel Therapeutics, Inc. annual Depreciation for 2022 was $1.46M, a 3.47% increase from 2021.
- Decibel Therapeutics, Inc. annual Depreciation for 2021 was $1.41M, a 13.9% decline from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)